NO20010049L - Forsterkningsfremgangsmåte for antitumoraktivitet av en substans som inneholder amygdalin, en sammensetning som inneholderen forsterket amygdalininneholdende substans, fremgangsmåte for åbedömme antitumorvirkning av behandling for amygdalininn - Google Patents

Forsterkningsfremgangsmåte for antitumoraktivitet av en substans som inneholder amygdalin, en sammensetning som inneholderen forsterket amygdalininneholdende substans, fremgangsmåte for åbedömme antitumorvirkning av behandling for amygdalininn

Info

Publication number
NO20010049L
NO20010049L NO20010049A NO20010049A NO20010049L NO 20010049 L NO20010049 L NO 20010049L NO 20010049 A NO20010049 A NO 20010049A NO 20010049 A NO20010049 A NO 20010049A NO 20010049 L NO20010049 L NO 20010049L
Authority
NO
Norway
Prior art keywords
amygdalin
substance
treatment
amplification procedure
assessing
Prior art date
Application number
NO20010049A
Other languages
English (en)
Norwegian (no)
Other versions
NO20010049D0 (no
Inventor
Kozo Niwa
Original Assignee
Kozo Niwa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kozo Niwa filed Critical Kozo Niwa
Publication of NO20010049D0 publication Critical patent/NO20010049D0/no
Publication of NO20010049L publication Critical patent/NO20010049L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20010049A 2000-01-17 2001-01-04 Forsterkningsfremgangsmåte for antitumoraktivitet av en substans som inneholder amygdalin, en sammensetning som inneholderen forsterket amygdalininneholdende substans, fremgangsmåte for åbedömme antitumorvirkning av behandling for amygdalininn NO20010049L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000008337A JP2001199892A (ja) 2000-01-17 2000-01-17 アミグダリン含有物の抗腫瘍活性強化方法、抗腫瘍活性強化アミグダリン含有物を含む組成物、アミグダリン含有物処理の抗腫瘍有効性評価方法、およびアミグダリン含有物の抗腫瘍有効性評価方法

Publications (2)

Publication Number Publication Date
NO20010049D0 NO20010049D0 (no) 2001-01-04
NO20010049L true NO20010049L (no) 2001-07-18

Family

ID=18536624

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010049A NO20010049L (no) 2000-01-17 2001-01-04 Forsterkningsfremgangsmåte for antitumoraktivitet av en substans som inneholder amygdalin, en sammensetning som inneholderen forsterket amygdalininneholdende substans, fremgangsmåte for åbedömme antitumorvirkning av behandling for amygdalininn

Country Status (19)

Country Link
US (2) US20010009903A1 (it)
JP (1) JP2001199892A (it)
KR (1) KR20010076279A (it)
CN (1) CN1319431A (it)
AU (1) AU1502101A (it)
CA (1) CA2331167A1 (it)
DE (1) DE10101543A1 (it)
DK (1) DK200100086A (it)
ES (1) ES2166741B1 (it)
FR (1) FR2805746A1 (it)
GB (1) GB2360211A (it)
ID (1) ID29765A (it)
IL (1) IL140900A0 (it)
IS (1) IS5804A (it)
IT (1) ITTO20010028A1 (it)
NL (1) NL1017117C2 (it)
NO (1) NO20010049L (it)
SE (1) SE0100083L (it)
ZA (1) ZA200100377B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3256746B2 (ja) * 2000-03-02 2002-02-12 高知医科大学長 細胞線維化を抑制する組成物及び枇杷核エキスの調製方法
KR100470294B1 (ko) * 2002-08-20 2005-02-05 (주) 한약마을 도인 또는 행인으로부터 아미그달린을 효과적으로 얻는추출방법
GB0402728D0 (en) * 2004-02-07 2004-03-10 Pharming Ltd Pesticides
JP2006197928A (ja) * 2004-12-22 2006-08-03 Yamaguchi Prefecture タケノコ麹及びその製造方法並びにタケノコ醗酵食品及びその製造方法
JP4974116B2 (ja) * 2005-06-27 2012-07-11 国立大学法人 鹿児島大学 ビワ葉抽出物を含有する飲食品及び医薬品
CN101190019B (zh) * 2006-11-21 2011-03-09 马玉林 杏仁酱及其制备方法
RU2348079C1 (ru) * 2007-09-05 2009-02-27 Государственное Образовательное Учреждение Высшего Профессионального Образования Амурская Государственная Медицинская Академия Росздрава Способ и устройство для экспериментального моделирования активации процессов перекисного окисления липидов биологических мембран
CN107400150A (zh) * 2017-08-16 2017-11-28 黄山市歙县绿色三潭枇杷生物科技有限公司 一种从枇杷核中提取苦杏仁苷的方法
CN113521084A (zh) * 2021-08-13 2021-10-22 唐秀全 一种苦杏仁苷含片及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6226228A (ja) * 1985-07-26 1987-02-04 Echigo Yakusou:Kk 粉末よもぎの製造法
JPS6379834A (ja) * 1986-09-25 1988-04-09 Kozo Niwa 活性酸素抑制組成物
JPH0193508A (ja) * 1987-06-09 1989-04-12 Sugiura Shinyaku Kaihatsu Kenkyusho:Kk ス−パ−オキシドディスムタ−ゼを高濃度に含有するキュウカンバエキス及びその製法
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
JP2955126B2 (ja) * 1992-06-22 1999-10-04 笑代 丹羽 医薬用油性製剤、食品用油性製剤およびそれらの製造方法
JPH06227998A (ja) * 1993-01-28 1994-08-16 Sanji Kumai ニトリル配糖体を含有する生薬エキスの制癌活性
JPH07165589A (ja) * 1993-12-13 1995-06-27 Tsumura & Co 脳機能改善剤
JPH07188044A (ja) * 1993-12-27 1995-07-25 Asahi Breweries Ltd 抗活性酸素作用組成物の製造法
JPH08140613A (ja) * 1994-11-17 1996-06-04 Toshiyuki Ota 食 品
GB2314800A (en) * 1996-12-05 1998-01-14 Henry Berry & Co Ltd Component assembly machine
JPH10298099A (ja) * 1997-04-23 1998-11-10 Kozo Niwa 細胞賦活組成物

Also Published As

Publication number Publication date
ID29765A (id) 2001-10-11
NL1017117C2 (nl) 2003-09-30
CN1319431A (zh) 2001-10-31
NL1017117A1 (nl) 2001-07-19
DK200100086A (da) 2001-07-18
SE0100083L (sv) 2001-07-18
ITTO20010028A1 (it) 2002-07-16
GB0101181D0 (en) 2001-02-28
IL140900A0 (en) 2002-02-10
US20010009903A1 (en) 2001-07-26
US20020098252A1 (en) 2002-07-25
CA2331167A1 (en) 2001-07-17
FR2805746A1 (fr) 2001-09-07
IS5804A (is) 2001-07-17
KR20010076279A (ko) 2001-08-11
ES2166741B1 (es) 2003-11-16
SE0100083D0 (sv) 2001-01-12
JP2001199892A (ja) 2001-07-24
ZA200100377B (en) 2001-07-18
GB2360211A (en) 2001-09-19
AU1502101A (en) 2001-07-19
DE10101543A1 (de) 2001-07-19
NO20010049D0 (no) 2001-01-04
ES2166741A1 (es) 2002-04-16
ITTO20010028A0 (it) 2001-01-16

Similar Documents

Publication Publication Date Title
Shen et al. Detoxification of aflatoxins in foods by ultraviolet irradiation, hydrogen peroxide, and their combination-a review
Diao et al. Ultraviolet irradiation detoxification of aflatoxins
Reis et al. Scientific evidence in antimicrobial photodynamic therapy: An alternative approach for reducing cariogenic bacteria
NO20010049L (no) Forsterkningsfremgangsmåte for antitumoraktivitet av en substans som inneholder amygdalin, en sammensetning som inneholderen forsterket amygdalininneholdende substans, fremgangsmåte for åbedömme antitumorvirkning av behandling for amygdalininn
Diao et al. Ozonolysis mechanism and influencing factors of aflatoxin B1: A review
Oruba et al. Antimicrobial photodynamic therapy—A discovery originating from the pre-antibiotic era in a novel periodontal therapy
WO2002038447A3 (en) Disinfection through packaging
JP2009013162A (ja) 光感作型ざ瘡治療剤、光感作型ざ瘡治療剤の組成物、光力学的ざ瘡治療用キット、光感作型皮脂分泌抑制剤、光感作型皮脂分泌抑制剤の組成物および光力学的皮脂分泌抑制剤キット
SG169224A1 (en) Method for treatment of tumors using nordihydrogualaretic acid derivatives
JP2025016514A (ja) 生体表面の治療方法
Riley et al. An in-vitro study of the sterilization of titanium dental implants using low intensity UV-radiation
Shivasaraun et al. Flavonoids as adjuvant in psoralen based photochemotherapy in the management of vitiligo/leucoderma
Xu et al. The decomposition of protoporphyrin IX by ultrasound is dependent on the generation of hydroxyl radicals
Choi et al. In vitro photodynamic antimicrobial activity of methylene blue and endoscopic white light against Helicobacter pylori 26695
Kreitner et al. Haematoporphyrin-and sodium chlorophyllin-induced phototoxicity towards bacteria and yeasts–a new approach for safe foods
Shirato et al. Time-kill kinetic analysis of antimicrobial chemotherapy based on hydrogen peroxide photolysis against Streptococcus mutans biofilm
Zhang et al. Effects of multi-wavelength ultraviolet radiation on the inactivation and reactivation of Escherichia coli in recirculating water system
Wang et al. Plasmonic hot-electron injection boosts piezocatalysis of barium titanate nanowires for dental biofilm eradication and tooth whitening
Hume et al. The effect of air, which has been exposed to the radiations of the mercury-vapour quartz lamp, in promoting the growth of rats, fed on a diet deficient in fat-soluble vitamins
MX2024006475A (es) Actividad fotodinamica contra bacterias gram positivas del rosa de bengala grado farmaceutico.
Jha et al. Investigation of antimicrobial activity of Ultraviolet B radiation and its potential to generate fructose-mediated reactive oxygen species in coconut water
Cao et al. Synergistic mechanism of combined UV-LEDs and peracetic acid treatment on inactivation of fungal spores
Hirakawa et al. Guanine-specific DNA damage photosensitized by the dihydroxo (tetraphenylporphyrinato) antimony (V) complex
AU2003283227A8 (en) Method and means for the treatment of vascular and cardiac diseases
Xu et al. Photochemical properties of gemifloxacin: A laser flash photolysis study

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application